2018 NCRI Cancer Conference - the UK's largest cancer conference is only a few weeks away. It will take place from Sunday 4 to Tuesday 6 November in Glasgow, UK. Registration for bona fide journalists is free.
The Conference attracts more than 1,500 delegates and will include 500 presentations from national and international leaders in cancer research. Topics range from epidemiology and research in the lab, to clinical trials of new treatments, and quality of life studies.
The media programme will include new findings on e-cigarettes, melanoma mortality, sleep and breast cancer, prostate cancer and glioma.
Media can register by email: firstname.lastname@example.org
Every session is open to journalists and registration is free of charge to journalists who are in possession of a valid, recognised press card. Freelance journalists must present a commissioning letter on headed paper from a recognised news organisation or publication. Full details can be found in the media policy: https:/
There will be a press office with internet connections onsite, run by media consultants, Kerry Noble and Emma Mason.
Journalist attending the Conference should visit the main registration desk then report to the press office to receive a press pack.
Press office opening times:
Sun 4 November 09:00 - 19.00 hrs (GMT)
Mon 5 November 08:00 - 18.00 hrs
Tue 6 November 08:00 - 17.30 hrs
For media queries about the Conference, contact Kerry and Emma:
Tel: +44 (0)7446 869 433
More information on the programme is available on the NCRI Cancer Conference website at: https:/
Social media: #NCRI2018
Information on accommodation in Glasgow can be found here:
Reservations are made on a first-come, first-served basis.
The Conference is run by the National Cancer Research Institute, a UK-wide partnership of cancer research funders that works together to accelerate progress in cancer-related research through collaboration, to improve health and quality of life. NCRI Partners: Biotechnology and Biological Sciences Research Council (BBSRC); Bloodwise; Brain Tumour Research, Breast Cancer Now; Cancer Research UK; Children with Cancer UK, Department of Health and Social Care; Economic and Social Research Council (ESRC); Macmillan Cancer Support; Marie Curie; Medical Research Council (MRC); Northern Ireland Health and Social Care Public Health Agency (Research & Development Department); Pancreatic Cancer Research Fund; Prostate Cancer UK; Roy Castle Lung Cancer Foundation; Scottish Government Health Directorates (Chief Scientist Office); Tenovus Cancer Care; The Wellcome Trust and Welsh Assembly Government (Health and Care Research Wales)
For more information visit: http://www.